Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International CentersMargherita Rimini, Su Yung‐Yeh, Jin Won Kim et al.|Liver International|2025Cited by 10
Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real‐World Cohort Treated With Cisplatin, Gemcitabine, and DurvalumabMargherita Rimini, Gian Paolo Spinelli, Angela Lamarca et al.|International Journal of Cancer|2026Cited by 0
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to <scp>TOPAZ</scp> ‐1 Study Eligibility: A Large Global Analysis in a Real‐World SettingFederica Lo Prinzi, Gian Paolo Spinelli, Margherita Rimini et al.|International Journal of Cancer|2026Cited by 0